Table 2.
Observed serum levels at baseline and after each treatment period (mean ± SD).
| Compound in Serum | All Baseline | Treatment Group | ||
|---|---|---|---|---|
| VitD3 | VitD2 | 25OH-D3 | ||
| 25OH-D3, nmol/L | 54.6 ± 9.0 | 52.9 ± 8.5 | 32.3 ± 7.1 | 62.7 ± 11.5 |
| 25OH-D2, nmol/L | 1.5 ± 1.0 | 2.2 ± 1.5 | 11.9 ± 3.1 | 2.1 ± 1.0 |
| Total 25OH-D, nmol/L | 56.1 ± 8.5 | 55.1 ± 8.9 | 44.2 ± 8.0 | 64.7 ± 11.2 |
| VitD3, nmol/L | 2.5 ± 1.5 | 2.0 ± 1.1 | 0.9 ± 0.8 | 0.8 ± 0.6 |
| VitD2, nmol/L | 0.04 ± 0.03 | 0.05 ± 0.04 | 0.3 ± 0.4 | 0.02 ± 0.01 |
| PTH, pmol/L | 3.2 ± 1.3 | 2.1 ± 0.7 | 2.8 ± 1.0 | 2.4 ± 0.9 |
| Calcium, nmol/L | 2.4 ± 0.1 | 2.5 ± 0.1 | 2.5 ± 0.1 | 2.5 ± 0.1 |